Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Aeon Biopharma Inc (AEON)

Aeon Biopharma Inc (AEON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
AEON Biopharma Reports Third Quarter 2025 Results, Including Positive ABP-450 Biosimilarity Data and Strategic Positioning for Continued Growth GlobeNewswire - Fri Nov 14, 7:30AM CST

– FDA Type 2a meeting scheduled for November 19, 2025, to review AEON’s analytical development plan and initial data – – Positive biosimilarity data for ABP-450 confirming identical amino-acid...

AEON : 0.9046 (-3.77%)
AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711 GlobeNewswire - Fri May 23, 3:05PM CDT

AEON : 0.9046 (-3.77%)
AEON Biopharma to Present at the Aegis Capital Corp. Virtual Conference 2025 GlobeNewswire - Mon May 19, 3:05PM CDT

AEON : 0.9046 (-3.77%)
AEON Biopharma Reports First Quarter 2025 Financial Results and Provides Corporate Update GlobeNewswire - Wed May 14, 3:05PM CDT

AEON : 0.9046 (-3.77%)
AEON Biopharma Announces NYSE American Acceptance of Plan to Regain Listing Compliance GlobeNewswire - Fri Apr 25, 3:05PM CDT

AEON : 0.9046 (-3.77%)
AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711 GlobeNewswire - Mon Apr 21, 3:10PM CDT

AEON : 0.9046 (-3.77%)
AEON Biopharma Appoints Industry Veteran Rob Bancroft as Chief Executive Officer GlobeNewswire - Mon Apr 21, 3:05PM CDT

AEON : 0.9046 (-3.77%)
Mineralys, Sana, Aeon: These 3 Biotech Stocks Saw The Sharpest Retail Interest Spike In Q1 Stocktwits - Tue Apr 1, 2:00AM CDT

Three small-cap stocks have intrigued Stocktwits users the most among the biotech sector this year, thanks to promising data from clinical trials and a leadership shuffle.

SANA : 3.99 (+9.02%)
MLYS : 40.85 (-7.77%)
AEON : 0.9046 (-3.77%)
AEON Biopharma Announces CEO Transition GlobeNewswire - Thu Mar 27, 3:05PM CDT

AEON : 0.9046 (-3.77%)
AEON Biopharma Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update GlobeNewswire - Mon Mar 24, 3:05PM CDT

AEON : 0.9046 (-3.77%)

Barchart Exclusives

Nvidia Has One of the ‘Largest’ Opportunities Ahead. Should You Buy NVDA Stock Before November 19? Barchart - Sat Nov 15, 11:00AM CST
Susquehanna analysts maintain a positive view and raised their price target from $210 to $230 ahead of Nov. 19 earnings. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot